0001209191-18-048410.txt : 20180824
0001209191-18-048410.hdr.sgml : 20180824
20180824172150
ACCESSION NUMBER: 0001209191-18-048410
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180822
FILED AS OF DATE: 20180824
DATE AS OF CHANGE: 20180824
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Currie Mark G
CENTRAL INDEX KEY: 0001478244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 181037715
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS INC
STREET 2: 320 BENT STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-22
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001478244
Currie Mark G
C/O IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Class B Common Stock
2018-08-22
4
M
0
16666
4.89
A
791666
D
Class B Common Stock
2018-08-22
4
M
0
41667
4.89
A
833333
D
Class B Common Stock
2018-08-22
4
M
0
6667
5.48
A
840000
D
Class B Common Stock
2018-08-22
4
S
0
65000
18.51
D
775000
D
Class B Common Stock
2018-08-23
4
M
0
16667
4.89
A
791667
D
Class B Common Stock
2018-08-23
4
M
0
41666
4.89
A
833333
D
Class B Common Stock
2018-08-23
4
M
0
6667
5.48
A
840000
D
Class B Common Stock
2018-08-23
4
S
0
65000
18.39
D
775000
D
Class A Common Stock
30124
D
Employee Stock Option (Right to Buy)
4.89
2018-08-22
4
M
0
16666
0.00
D
2019-02-11
Class B Common Stock
16666
33334
D
Employee Stock Option (Right to Buy)
4.89
2018-08-22
4
M
0
41667
0.00
D
2019-02-11
Class B Common Stock
41667
83333
D
Employee Stock Option (Right to Buy)
5.48
2018-08-22
4
M
0
6667
0.00
D
2019-07-28
Class B Common Stock
6667
33333
D
Employee Stock Option (Right to Buy)
4.89
2018-08-23
4
M
0
16667
0.00
D
2019-02-11
Class B Common Stock
16667
16667
D
Employee Stock Option (Right to Buy)
4.89
2018-08-23
4
M
0
41666
0.00
D
2019-02-11
Class B Common Stock
41666
41667
D
Employee Stock Option (Right to Buy)
5.48
2018-08-23
4
M
0
6667
0.00
D
2019-07-28
Class B Common Stock
6667
26666
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. In order to effect the sale, these shares of Class B Common Stock were converted into shares of Class A Common Stock in accordance with the issuer's certificate of incorporation.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.66, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option was fully vested as of its grant date of February 12, 2009.
The option vested as to 1.25% of the shares of Class B Common Stock on each monthly anniversary of January 1, 2009 for the first 36 months, and as to 4.5833% of the shares of Class B Common Stock on each monthly anniversary thereafter. The option was fully vested as of January 1, 2013.
The option vests in two equal installments based on the issuer's achievement of certain regulatory and commercial milestones. Upon achievement of a regulatory milestone, the option vested as to 20,000 shares of Class B Common Stock on January 4, 2017.
/s/ Conor Kilroy, Attorney-in-Fact
2018-08-24